The Archives

The collection of all scholarly commentary on law, economics, and more

Showing results for:  “Valid C1000-170 Study Materials ๐Ÿ•— C1000-170 Latest Exam Answers ๐Ÿฎ Trusted C1000-170 Exam Resource ๐Ÿฆ Search on ใ€ www.pdfvce.com ใ€‘ for ใ€ C1000-170 ใ€‘ to obtain exam materials for free download ๐Ÿ€Valid C1000-170 Dumps Demo”

How the Facebook Claimโ€™s Intellectual Foundations Doomed Its Argument

The UK Competition Appeal Tribunal (CAT) recently handed down a judgment refusing to allow “the Facebook Claim”—among the more well-known UK competition-law class-action cases—to proceed to trial. While the case failed to receive the necessary certification, it may yet fight another day, provided that it undergoes, as the CAT put it, a “root and branch ... How the Facebook Claimโ€™s Intellectual Foundations Doomed Its Argument

While Congress Delays, the Task Force Will Play

With the first day of summer less than a week away and political silly season just around the corner, we don’t have much time for hootenannies. Congress needs to channel the wisdom of Jerry Reed, who noted: “We’ve got a long way to go and a short time to get there.” In early March, Congress ... While Congress Delays, the Task Force Will Play

NLRB Targeting of Noncompetes Lacks a Sound Legal Foundation

Jennifer Abruzzo, general counsel of the National Labor Relations Board (NLRB), recently issued a memo claiming that certain noncompete clauses in labor contracts are illegal, on grounds that they violate employees’ right to organize and negotiate better working conditions under Section 7 of the National Labor Relations Act (NLRA). The NLRB isn’t the first Biden ... NLRB Targeting of Noncompetes Lacks a Sound Legal Foundation

Oregon Should Beware the Right to Repair

The Oregon State Legislature is considering HB 3631, a bill that would ensure that consumers have a “right to repair” their electronics devices. The legislation would require that manufacturers provide consumers and independent repair shops access to relevant repair information, as well to make available any parts or tools necessary to carry out the repair. ... Oregon Should Beware the Right to Repair

FTC v Amgen: The Economics of Bundled Discounts, Part Two

The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. The challenge represents a landmark in the history of pharmaceutical-industry antitrust enforcement, as the industry has largely been given license to engage in permissive mergers and acquisitions of smaller companies without challenge. In Part One, ... FTC v Amgen: The Economics of Bundled Discounts, Part Two

Two FCC Commissioners Walk Into a Bar

Former FCC Commissioners Have Some Thoughts Writing with Kirk Arner in RealClearMarkets, Harold Furchtgott-Roth—formerly of the Federal Communications Commission (FCC)—comments on the Spectrum Auction Reauthorization Act, recently passed out of the House Energy and Commerce Committee. Arner and Furchtgott-Roth note that reauthorizing spectrum auctions is a “good and necessary idea,” but take issue with the “$23 billion Ponzi ... Two FCC Commissioners Walk Into a Bar

Antitrust Regulators Should Be Careful Not to Shank the PGA-LIV Deal

In a world in which so-called “Big Tech” has dominated antitrust discussions for a decade or more, who would’ve guessed that golf would grab the biggest headlines? The proposed merger of the PGA Tour and LIV Golf has some major headline-grabbing potential: sports, big money, big names, 9/11, human-rights abuses, and cringeworthy public-relations attempts. Aside ... Antitrust Regulators Should Be Careful Not to Shank the PGA-LIV Deal

Dynamic Competition Proves There Is No Captive Audience: 10 Years, 10G, and YouTube TV

In Susan Crawford’s 2013 book “Captive Audience: The Telecom Industry and Monopoly Power in the New Gilded Age,” the Harvard Law School professor argued that the U.S. telecommunications industry had become dominated by a few powerful companies, leading to limited competition and negative consequences for consumers, especially for broadband internet. Crawford’s ire was focused particularly ... Dynamic Competition Proves There Is No Captive Audience: 10 Years, 10G, and YouTube TV

FTC v Amgen: The Economics of Bundled Discounts, Part One

The Federal Trade Commission (FTC) recently announced that it would seek to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. The move was the culmination of several years’ worth of increased scrutiny from both Congress and the FTC into antitrust issues in the biopharmaceutical industry. While the FTC’s move didn’t elicit much public comment, ... FTC v Amgen: The Economics of Bundled Discounts, Part One

The Robinson-Patman Act: The Anti-Consumer Welfare Statute

Consistent with the neo-Brandeisian penchant for downplaying (some would say ignoring) consumer-welfare concerns, the Federal Trade Commission (FTC) recently touted its interest in “reinvigorating” enforcement of the Robinson-Patman Act (RPA). This would stand sensible antitrust-enforcement policy on its head, by devoting resources to actions that predictably would tend to diminish consumer welfare. In the hope ... The Robinson-Patman Act: The Anti-Consumer Welfare Statute

Thereโ€™s Nothing โ€˜Fairโ€™ About EU Telecomsโ€™ Proposed โ€˜Fair Shareโ€™ Plan

The European Commission’s recently concluded consultation on “the future of the electronic communications sector and its infrastructure” was a curious phenomenon in which the commission revived the seemingly dead-and-buried idea of a legally mandated “sender pays” network-traffic scheme, despite the fact that it remains as unpopular and discredited as it was when last discussed roughly ... Thereโ€™s Nothing โ€˜Fairโ€™ About EU Telecomsโ€™ Proposed โ€˜Fair Shareโ€™ Plan

Antitrust at the Agencies Roundup: Pruning the Data Tree Edition

In my last roundup, I puzzled over the Federal Trade Commission’s (FTC) suit to block Amgen’s acquisition of Horizon Therapeutics. The deal involved no product overlaps whatsoever (i.e., no horizontal competition), a target firm acknowledged to have no competitors for the orphan drugs at issue, and nobody poised to enter into competition either. I won’t ... Antitrust at the Agencies Roundup: Pruning the Data Tree Edition